Manju Bhavnani
Manju Bhavnani publishes mostly in Hematology, Genetics and Immunology, on topics such as Immunodeficiency and Autoimmune Disorders, Chronic Lymphocytic Leukemia Research and Atrial Fibrillation Management and Outcomes.
- World rank
- #6,598,832 of 7,710,434 ranked researchers
- Rank in United Kingdom
- #350,278 of 367,258
- Works
- 40
- Citations
- 666
- Citations per work
- 16.7
What does Manju Bhavnani research?
Manju Bhavnani's work is mostly in Medicine (42%), Biochemistry, Genetics and Molecular Biology (11%), Immunology and Microbiology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1742.5%
- Medicine1742.5%
- Everything else1538.7%
- Life Sciences818.8%
- 1Hematology22% of their works
- 2Genetics14% of their works
- 3Immunology8% of their works
- 4Cardiology and Cardiovascular Medicine7% of their works
- 5Molecular Biology7% of their works
- 6Genetics5% of their works
Research topics
- Immunodeficiency and Autoimmune Disorders
- Chronic Lymphocytic Leukemia Research
- Atrial Fibrillation Management and Outcomes
- Acute Myeloid Leukemia Research
- Blood disorders and treatments
- Venous Thromboembolism Diagnosis and Management
- Blood Coagulation and Thrombosis Mechanisms
- Lymphoma Diagnosis and Treatment
Which keywords describe Manju Bhavnani's research?
The keywords of their largest research topics: Prognostic Factors, Genetic Mutations, Rituximab, Hematopoietic Stem Cells, Antithrombotic Therapy, Chronic Lymphocytic Leukemia, Genomic Aberrations and Immune Dysregulation.
- Protease-Activated Receptors
- Classification
- Pulmonary Embolism
- Congenital Disorders
- AML
- Anticoagulant Therapy
- Immune Dysregulation
- Chronic Lymphocytic Leukemia
- Hematopoietic Stem Cells
- Genetic Mutations
- Prognostic Factors
- Rituximab
- Antithrombotic Therapy
- Genomic Aberrations
- Primary Immunodeficiency
- Atrial Fibrillation
- Acute Myeloid Leukemia
- Neutropenia
- Venous Thromboembolism
- Lymphoma
- Thrombin
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 21 words, with their numbers
- Prognostic Factors142 topics
- Genetic Mutations132 topics
- Rituximab122 topics
- Hematopoietic Stem Cells112 topics
- Antithrombotic Therapy92 topics
- Chronic Lymphocytic Leukemia81 topic
- Genomic Aberrations81 topic
- Immune Dysregulation81 topic
- Primary Immunodeficiency81 topic
- Anticoagulant Therapy71 topic
- Atrial Fibrillation71 topic
- AML61 topic
- Acute Myeloid Leukemia61 topic
- Congenital Disorders51 topic
- Neutropenia51 topic
- Pulmonary Embolism51 topic
- Venous Thromboembolism51 topic
- Classification41 topic
- Lymphoma41 topic
- Protease-Activated Receptors41 topic
- Thrombin41 topic
Where does Manju Bhavnani work?
Manju Bhavnani's main affiliation in the publication record is Royal Albert Edward Infirmary, United Kingdom.
How many publications and citations does Manju Bhavnani have?
OpenAlex counts 40 works and 666 citations for Manju Bhavnani, an h-index of 14, ranking #6,598,832 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Manju Bhavnani. Posts are plain text and can be reported.